Ian C. Eperon

15.8k citations

75 papers · 12.7k indexed · 2 hit papers · h-index 34

Impact in

Clinical Biochemistry top 0.05%
- Metabolism and Genetic Disorders
Molecular Biology top 0.2%
- Mitochondrial Function and Pathology
- RNA and protein synthesis mechanisms
- RNA modifications and cancer
- Genomics and Phylogenetic Studies
- RNA Research and Splicing
- ATP Synthase and ATPases Research

Papers in

Molecular Biology 70
- RNA and protein synthesis mechanisms 45
- RNA Research and Splicing 39
- RNA modifications and cancer 27
- RNA Interference and Gene Delivery 11
- DNA and Nucleic Acid Chemistry 11
- Genomics and Phylogenetic Studies 6
- Mitochondrial Function and Pathology 5
Structural Biology 1

Co-authors: Stephen K. Anderson Ian G. Young Frederick Sanger Alan Coulson M.H.L. de Bruijn Donald P. Nierlich Peter Schreier B.A. Roe
Journals: Nucleic Acids Research (15 papers)Proceedings of the National Academy of Sciences (4 papers)Biochemical Society Transactions (4 papers)Journal of Molecular Biology (4 papers)Molecular and Cellular Biology (4 papers)
Partner nations: United Kingdom United States Russia

In The Last Decade

Ian C. Eperon

75 papers receiving 12.2k citations

Hit Papers

align trajectories log scale

Complete sequence of bovine mitochondrial DNA conserved features of the mammalian mitochondrial genome 1982 · 1.3k citations

Peers

Countries citing papers authored by Ian C. Eperon

Since Specialization

Citations

This map shows the geographic impact of Ian C. Eperon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian C. Eperon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian C. Eperon more than expected).

Fields of papers citing papers by Ian C. Eperon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian C. Eperon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian C. Eperon. The network helps show where Ian C. Eperon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ian C. Eperon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ian C. Eperon Line = papers co-authored together Ian C. Eperon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Surface Passivation with a Perfluoroalkane Brush Improves the Precision of Single-Molecule Measurements ACS Applied Materials & Interfaces ·Carlos J. Bueno-Alejo, Ing S, Amanda K. Chaplin, Susumu Uchiumi, 周二天沼, Glenn A. Burley, Cyril Dominguez, Stephen J. Hardiman, 芦冬兰, Nkazimulo Precious Mahlangu, Ian C. Eperon, Alasdair W. Clark, Andrew J. Hudson	2022	11
2	The mechanisms of a mammalian splicing enhancer Nucleic Acids Research ·Licia Russo, F Ferling, Karini Carvalho Costa, Andrew J. Hudson, Glenn A. Burley, Ian C. Eperon	2018	29
3	Specific G-quadruplex ligands modulate the alternative splicing of Bcl-X Nucleic Acids Research ·Zahara Lasso Paredes, Bastin Robins. J, Vijay Gokhale, Yongqiang Xi, Isabelle Behm‐Ansmant, Glenn A. Burley, Christiane Branlant, Laurence H. Hurley, Cyril Dominguez, Ian C. Eperon	2017	52
4	Structural basis of RNA recognition and dimerization by the STAR proteins T-STAR and Sam68 Nature Communications ·Mikaël Feracci, 潔平木, Sushma Nagaraja Grellscheid, Marina Danilenko, Ralf Stehle, 松本通晴, Hyun-Seo Kang, Caroline Dalgliesh, N. Helge Meyer, Yilei Liu, Le-Yan Pan, Michael Sattler, Ian C. Eperon, David J. Elliott, Cyril Dominguez	2016	50
5	A Targeted Oligonucleotide Enhancer of SMN2 Exon 7 Splicing Forms Competing Quadruplex and Protein Complexes in Functional Conditions Cell Reports ·Lindsay Smith, Alderman James G. Howell, Karini Carvalho Costa, Akmarina binti Mohd Salwai, Alexey A. Malygin, Zahara Lasso Paredes, Tian Le, Andrew R. Bottrill, Mark S. Searle, Glenn A. Burley, Ian C. Eperon	2014	13
6	A Novel Morpholino Oligomer Targeting ISS-N1 Improves Rescue of Severe Spinal Muscular Atrophy Transgenic Mice Human Gene Therapy ·Haiyan Zhou, Narinder Janghra, Chalermchai Mitrpant, Alderman James G. Howell, Karen Anthony, Loren Price, Ian C. Eperon, Steve D. Wilton, Jennifer E. Morgan, Francesco Muntoni	2013	100
7	Intron Retention in the Alternatively Spliced Region of RON Results from Weak 3’ Splice Site Recognition PLoS ONE ·Lindsay Smith, Karini Carvalho Costa, Ian C. Eperon	2013	5
8	The transition in spliceosome assembly from complex E to complex A purges surplus U1 snRNPs from alternative splice sites Nucleic Acids Research ·Martin J. Hodson, Andrew J. Hudson, Dmitry Cherny, Ian C. Eperon	2012	20
9	Pro-metastatic splicing of Ron proto-oncogene mRNA can be reversed: Therapeutic potential of bifunctional oligonucleotides and indole derivatives RNA Biology ·Claudia Ghigna, Marion de Toledo, Serena Bonomi, Cristina Valacca, Stefania Gallo, Maria Apicella, Ian C. Eperon, Jamal Tazi, Giuseppe Biamonti	2010	55
10	Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts Proceedings of the National Academy of Sciences ·L. Skordis, Matthew G. Dunckley, Baigong Yue, Ian C. Eperon, Francesco Muntoni	2003	223
11	Murine serine proteases MASP-1 and MASP-3, components of the lectin pathway activation complex of complement, are encoded by a single structural gene Genes and Immunity ·Cordula Stover, Nicholas J. Lynch, Mads Ronald Dahl, Steven Hanson, Minoru Takahashi, Marion Frankenberger, Löms Ziegler-Heitbrock, Ian C. Eperon, Steffen Thiel, Wilhelm Schwaeble	2003	12
12	Selection of Alternative 5′ Splice Sites: Role of U1 snRNP and Models for the Antagonistic Effects of SF2/ASF and hnRNP A1 Molecular and Cellular Biology ·Ian C. Eperon, Olga V. Makarova, Akila Mayeda, Stephen H. Munroe, Javier F. Cáceres, Daniel Hayward, Adrian R. Krainer	2000	158
13	The Pre-mRNA 5′ Cap Determines Whether U6 Small Nuclear RNA Succeeds U1 Small Nuclear Ribonucleoprotein Particle at 5′ Splice Sites Molecular and Cellular Biology ·Uma Saxena, Ian C. Eperon	1998	31
14	Selective Amplification of T-Cell Receptor Variable Region Species Is Demonstrable but Not Essential in Early Lesions of Psoriasis Vulgaris: Analysis by Anchored Polymerase Chain Reaction and Hypervariable Region Size Spectratyping Journal of Investigative Dermatology ·直人永倉, Jessica Stolz, Tamara McNeill, Xihang Wei, Ian C. Eperon, R.D.R. Camp	1997	29
15	Alternative Splicing of a Human α-Tropomyosin Muscle-Specific Exon: Identification of Determining Sequences Molecular and Cellular Biology ·Ian R. Graham, Marion Hamshere, Ian C. Eperon	1992	42
16	Co‐purification of a small RNA species with multicatalytic proteinase (proteasome) from rat liver FEBS Letters ·Jiahan Xu, Ian C. Eperon, A. Jennifer Rivett	1991	18
17	Influences of separation and adjacent sequences on the use of alternative 5′ splice sites Journal of Molecular Biology ·Stuart Cunningham, 崔青扬, Larissa Watkins, Ian C. Eperon	1991	28
18	The dependence of splicing efficiency on the length of 3' exon Nucleic Acids Research ·Wojoud A Alruhaimi, 崔青扬, Ian C. Eperon	1988	18
19	Effects of RNA secondary structure on alternative splicing of Pre-mRNA: Is folding limited to a region behind the transcribing RNA polymerase? Cell ·Osypenko Ganna, Ian R. Graham, Andrew D. Griffiths, Ian C. Eperon	1988	254
20	Comparison of the Human and Bovine Mitochondrial Genomes Cold Spring Harbor Monograph Archive ·Stephen Anderson, Alan T. Bankier, B. G. Barrell, Moath Alshammari, Alan Coulson, Jacques Drouin, Ian C. Eperon, Donald P. Nierlich, Bruce A. Roe, Frederick Sanger, Peter Schreier, Andrew J. H. Smith, Kavita S. panday, Ian G. Young	1982	31

About Ian C. Eperon

Ian C. Eperon is a scholar working on Molecular Biology, Structural Biology, Genetics, Biophysics and Clinical Biochemistry, having authored 75 papers that have together received 12.7k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (45 papers), RNA Research and Splicing (39 papers), RNA modifications and cancer (27 papers), RNA Interference and Gene Delivery (11 papers), DNA and Nucleic Acid Chemistry (11 papers), Genomics and Phylogenetic Studies (6 papers), Mitochondrial Function and Pathology (5 papers) and Neurogenetic and Muscular Disorders Research (5 papers). The work is most often cited by research in Clinical Biochemistry (2.1k citations), Molecular Biology (10.7k citations), Genetics (3.0k citations), Aging (98 citations) and Paleontology (295 citations). Ian C. Eperon has collaborated with scholars based in United Kingdom, United States and Russia. Frequent co-authors include Stephen K. Anderson, Ian G. Young, Frederick Sanger, Alan Coulson, M.H.L. de Bruijn, Donald P. Nierlich, Peter Schreier, B.A. Roe, B. G. Barrell and Alan T. Bankier. Their work appears in journals such as Nucleic Acids Research, Proceedings of the National Academy of Sciences, Biochemical Society Transactions, Journal of Molecular Biology and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact